We had a clerk teaching session on asthma, and I thought I would share some points with everyone:
Diagnosis
Relative increase in FEV1 of 12% post-bronchodil AND over 200cc change. More sensitive test is methylcholine challenge
Steps for therapy: With each, patient education, environmental control
1) SABA prn
2) low dose ICS
3) (low dose ICS + LABA) or medium dose ICS
4) medium dose ICS + LABA
5) high dose ICS + LABA and consider omalizumab for allergic asthma (eosinophilia or symptoms)
6) high dose ICS + LABA + oral steroid and consider omalizumab
Before stepping up treatment, check puffer technique, adherence, environmental control, comorbidity.
Note that LABAs are never used without inhaled steroids; LABA alone increased mortality in trials
Do not step down unless asthma is well controlled for 3 months.
Parameters of control
daytime sx less than 4x/wk night sx less than 1x/wk normal physical activity mild, infrequent exac, no absenteeism B2 agonist use less than 4x/wk peak flow or FEV1 over 90% of best
Some general differences between asthma and COPD
1) reversible vs fixed obstruction
2) steroid responsiveness higher in asthma than COPD
3) small role for anticholinergics in asthma
4) very rarely use abx for exacerbations in asthma
5) dyspnea, tightness, wheeze in asthma vs dyspnea, cough, sputum in copd
6) early vs. late onset
In the non-responding asthmatic, think about:
1) poor compliance
2) poor inhaler technique
3) environment
4) drugs- B-bl, ASA
5) comorbitites- GERD, sinusitis, allergies, CHF
6) complications- ABPA, churg-strauss, chronic eosinophilic pneumonia
7) psychosocial
8) wrong diagnosis- consider vocal cord dysfcn, airway obstruction, CF (adult)
Links:
Click here for the 2007 NIH asthma guidelines
Acknowledgement:
Some of the above is taken from the University of Toronto Department of Respirology resident handbook
No comments :
Post a Comment